Philip Morris Tobacco

FDA will allow ZYN Nicotine pouches to stay on market

Philip Morris’s Zyn nicotine pouch isn’t safe, but FDA gives OK to marketing it

Shares of Philip Morris extended their recent bounce Thursday after the U.S. Food and Drug Administration authorized the marketing of 20 of the tobacco company’s Zyn nicotine pouches.

health.wusf.usf.edu · 22h

Zyn nicotine pouches can be marketed in the U.S., the FDA says. What does this mean?

The FDA said "an extensive scientific review" found the products were found to pose lower risks of cancer and other serious health conditions compared to cigarettes and smokeless tobacco products.

Stocktwits on MSN · 1d

Philip Morris Stock Rises On FDA Approval For Zyn Nicotine Pouches: Retail’s Upbeat

Shares of Philip Morris International Inc. ($PM) rose more than 1% on Thursday after the US Food and Drug Administration (FDA) authorized marketing of its Zyn nicotine pouch products, lifting retail sentiment.

2don MSN

FDA OKs sales of Zyn nicotine pouches, citing health benefits for adult smokers

Federal health officials on Thursday backed the public health benefits of nicotine pouches, authorizing Philip Morris ...

Zacks.com on MSN3d

Philip Morris Resilient on Smoke-Free Transition Efforts and Pricing

PM's solid fundamentals and commitment to innovation and cost efficiencies position the company well for sustained growth ...

Philip Morris International Inc. (PM): A Bull Case Theory

We came across a bullish thesis on Philip Morris International Inc. (PM) on Substack by Chit Chat Stocks. In this article, we ...

3 Reasons to Buy British American Tobacco Stock Like There's No Tomorrow

Despite persistent regulatory uncertainty and declining cigarette usage worldwide, the tobacco industry is alive and well in ...

CBS News3d

FDA moves to cut nicotine from cigarettes, in plan first floated under Trump

"In the late 1980s and early 1990s, Philip Morris sold a very low-nicotine cigarette called Next. Now, it was not commercially successful. But I believe that Philip Morris more than 30 years ...

11d

Philip Morris: Shift To Smoke-Free Sparks Steady Dividend Growth

Learn how Philip Morris International plans to shift to smoke-free products by 2030 to mitigate risks, boost profits, and ...

Buy Rating for Philip Morris: Strategic Positioning and FDA Approval of ZYN Pouches

Analyst Lisa Lewandowski from Bank of America Securities maintained a Buy rating on Philip Morris (PM – Research Report) and keeping the price ...

STAT3d

FDA proposes nicotine limits on tobacco products to make them less addictive

A proposed FDA rule would set nicotine levels on tobacco products at less than half the current average and could save ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results